Sight Sciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Sight Sciences and other ETFs, options, and stocks.About SGHT
Sight Sciences, Inc. is an ophthalmic medical device company, which focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. It operates through the Surgical Glaucoma and Dry Eye segments.
CEOPaul Badawi
CEOPaul Badawi
Employees216
Employees216
HeadquartersMenlo Park, California
HeadquartersMenlo Park, California
Founded2011
Founded2011
Employees216
Employees216
SGHT Key Statistics
Market cap430.90M
Market cap430.90M
Price-Earnings ratio-9.37
Price-Earnings ratio-9.37
Dividend yield—
Dividend yield—
Average volume199.69K
Average volume199.69K
High today$8.73
High today$8.73
Low today$8.08
Low today$8.08
Open price$8.41
Open price$8.41
Volume179.03K
Volume179.03K
52 Week high$8.80
52 Week high$8.80
52 Week low$2.03
52 Week low$2.03
Stock Snapshot
The current Sight Sciences(SGHT) stock price is $8.15, with a market capitalization of 430.9M. The stock trades at a price-to-earnings (P/E) ratio of -9.37.
On 2025-12-17, Sight Sciences(SGHT) stock moved within a range of $8.08 to $8.73. With shares now at $8.15, the stock is trading +0.9% above its intraday low and -6.6% below the session's peak.
Trading activity shows a volume of 179.03K, compared to an average daily volume of 199.69K.
The stock's 52-week range extends from a low of $2.03 to a high of $8.80.
The stock's 52-week range extends from a low of $2.03 to a high of $8.80.
Analyst ratings
57%
of 7 ratingsBuy
42.9%
Hold
57.1%
Sell
0%
People also own
Based on the portfolios of people who own SGHT. This list is generated using Robinhood data, and it’s not a recommendation.